A Phase 1 Study to Assess the Safety of ARRY-334543 With Capecitabine in Patients With Advanced Cancer.

Trial Profile

A Phase 1 Study to Assess the Safety of ARRY-334543 With Capecitabine in Patients With Advanced Cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Sep 2012

At a glance

  • Drugs Capecitabine; Varlitinib
  • Indications Cancer
  • Focus Adverse reactions; Biomarker; Pharmacokinetics
  • Most Recent Events

    • 05 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Apr 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
    • 06 Apr 2011 Planned End Date changed from 1 Aug 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top